logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Maki Tanioka

Okayama University
H指数:22
被引数:1,685

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

HER2阳性早期乳腺癌（EBC）患者新辅助治疗期间残留病灶（RD）生物学及基因表达变化的预后价值

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Fernandez-Martinez, A.; Tanioka, M.; Ahn, S. G.; Zagami, P.; Pascual, T.; Rediti, M.; Tang, G.; Hoadley, K. A.; Venet, D.; Rashid, N. U.; Spears, P. A.; Llombart-Cussa, A.; Di Cosimo, S.; de Azambuja, E.; Choudhury, A.; Rastogi, P.; Islam, M. N.; Swain, S. M.; Cortes, J.; Sotiriou, C.; Prat, A.; Perou, C. M.; Carey, L. A.
Interim analysis of prospective observational study to evaluate the impact of cancer gene panel tests on treatment decision making in metastatic or recurrent breast cancer in Japan: JBCRG-C07 REIWA study

前瞻性观察性研究的 interim analysis，旨在评估癌症基因-panel tests 对日本转移性或复发性乳腺癌治疗决策的影响：JBCRG-C07 REIWA 研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Masuda, H.; Hattori, M.; Tada, H.; Sagara, Y.; Adachi, Y.; Iwatani, T.; Uemoto, Y.; Otani, Y.; Kajiwara, Y.; Kitagawa, D.; Kogawa, T.; Shien, T.; Tanabe, Y.; Tanioka, M.; Hara, F.; Yasojima, H.; Yoshimura, K.; Iwata, H.; Masuda, N.
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in HER2+early-breast cancer (EBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Fernandez-Martinez, Aranzazu; Tanioka, Maki; Ahn, Sung Gwe; Zagami, Paola; Pascual, Tomas; Rediti, Mattia; Tang, Gong; Hoadley, Katherine A.; Venet, David; Rashid, Naim U.; Spears, Patty; Bliss, Judith; Huober, Jens; Rastogi, Priya; Islam, Md N.; Cortes, Javier; Llombart-Cussac, Antonio; Swain, Sandra; Sotiriou, Christos; Prat, Aleix; Perou, Charles M.; Carey, Lisa
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
BREAST CANCER RESEARCH AND TREATMENT
IF3
2022-11-169
OAAI
Yazaki, Shu; Shimoi, Tatsunori; Yoshida, Masayuki; Sumiyoshi-Okuma, Hitomi; Arakaki, Motoko; Saito, Ayumi; Kita, Shosuke; Yamamoto, Kasumi; Kojima, Yuki; Nishikawa, Tadaaki; Tanioka, Maki; Sudo, Kazuki; Noguchi, Emi; Murata, Takeshi; Shiino, Sho; Takayama, Shin; Suto, Akihiko; Ohe, Yuichiro; Fujiwara, Yasuhiro; Yonemori, Kan
Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

循环肿瘤DNA在晚期罕见癌症中的临床应用

FRONTIERS IN ONCOLOGY
IF3.3
2021-11-242
OAAI
Okuma, Hitomi Sumiyoshi; Yonemori, Kan; Kojima, Yuki; Tanioka, Maki; Sudo, Kazuki; Noguchi, Emi; Hijioka, Susumu; Wakakuwa, Keiko; Kato, Ken; Hirakawa, Akihiro; Kuchiba, Aya; Kubo, Takashi; Ichikawa, Hitoshi; Yoshida, Akihiko; Yatabe, Yasushi; Nakamura, Kenichi; Mano, Hiroyuki; Yamamoto, Noboru; Fujiwara, Yasuhiro

研究方向

暂未获取到该数据
Y
Yoshiki Miyachi
H 指数:78论文数:926被引数:2.5万
K
Kan Yonemori
H 指数:48论文数:1,048被引数:1.0万
T
Tatsunori Shimoi
H 指数:21论文数:358被引数:2,491
K
Kazuki Sudo
H 指数:29论文数:491被引数:3,021
E
Emi Noguchi
H 指数:17论文数:133被引数:1,079
Y
Yuki Kojima
H 指数:20论文数:350被引数:1,500
H
Hitomi Sumiyoshi Okuma
H 指数:14论文数:260被引数:576
T
Tadaaki Nishikawa
H 指数:17论文数:174被引数:1,752
S
S. Kore-eda
H 指数:15论文数:85被引数:626
Y
Yasuhiro Fujiwara
H 指数:65论文数:973被引数:1.7万